Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Evaluation of Resection Techniques for Pancreatic Tumors

NCT ID: NCT05128890Sponsor: Methodist Health SystemLast updated: 2026-03-20

Summary

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Detailed description

The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.

Arms & interventions

  • ProcedureResection techniques for pancreatic and liver tumors

    to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint

Outcome measures

Primary

  • Patient Survival

    It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.

    Time frame: through study completion, an average of 1 year

  • Length of stay

    It will be calculated in days. The days stayed in hospital post-procedure.

    Time frame: Up to 1 year

  • Complication rates

    Patient may visit physician or hospital for any symptoms or may need hospitalizations.

    Time frame: through study completion, an average of 1 year

  • Operative time

    The time required for the procedure.

    Time frame: up to 10 hours

  • Transfusion rate

    If any post-procedure transfusion required, will be recorded.

    Time frame: through study completion, an average of 1 year

  • 30 and 90 day readmission rate

    After the procedure any hospital admissions up to 30 days will be recorded.

    Time frame: through study completion, an average of 1 year

  • Hospital charges

    The hospital charges for the procedure will be recorded.

    Time frame: through study completion, an average of 1 year

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older Exclusion Criteria: * Patients that have not undergone pancreatic resection surgeries * Patients under 18 years of age

Study locations (1)

Methodist Dallas Medical Center

Dallas, Texas, 75203

Recruiting
Colette N Ndjom, MS · Contact
Jennifer Kirchner · Contact
Alejandro Mejia, MD · Principal Investigator
Evaluation of Resection Techniques for Pancreatic Tumors | Cancerify